Chart

Myriad Genetics Inc

MYGN

Jan 1 1970 00:00:00

5.84

▲0.1600▲2.82%

Open5.69

High5.89

Low5.67

Close5.68

Volume52.46k

EPS

-4.33

P/E

-1.35

Market Cap

544.37M

Outstanding Shares

93.21M

Soon

Sentiment

Soon

Options

Recent Filings

ID: 0001517026-24-000006

ID: 0001922964-24-000008

ID: 0001843872-24-000004

ID: 0000899923-24-000048

ID: 0001517026-24-000004

ID: 0001843568-24-000006

ID: 0001932320-24-000008

ID: 0002002698-24-000419

ID: 0001628280-24-040232

ID: 0001922964-24-000006

You might find these companies interesting

Lantheus Holdings, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

In Vitro & In Vivo Diagnostic Substances (2835)

Achieve Life Sciences, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Tnf Pharmaceuticals, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

In Vitro & In Vivo Diagnostic Substances (2835)

Nymox Pharmaceutical Corp

In Vitro & In Vivo Diagnostic Substances (2835)

In Vitro & In Vivo Diagnostic Substances (2835)

Trinity Biotech Plc

In Vitro & In Vivo Diagnostic Substances (2835)

Immucell Corp /De/

In Vitro & In Vivo Diagnostic Substances (2835)

In Vitro & In Vivo Diagnostic Substances (2835)

Navidea Biopharmaceuticals, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Burzynski Research Institute Inc

In Vitro & In Vivo Diagnostic Substances (2835)

Moonlake Immunotherapeutics

Pharmaceutical Preparations (2834)

Cullinan Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)